Markit Tissue Marker-1ML Markit Tissue Marker-3ML Markit Tissue Marker-10ML
Marker, Radiographic, Implantable. 510(k) K121964, from Augmenix, Inc. (Waltham, MA). Product code NEU, class 2.
As of Nov 21, 2026, K121964 is an FDA 510(k) held by Augmenix, Inc., substantially equivalent on Jan 23, 2013 after 202 days, with no recalls tied to it in FDA's recall database.
- Review time: 202 days
- Recalls: 0
TraceIT™ Tissue Marker is indicated for use to radiographically mark soft tissue during a surgical procedure or for future surgical procedures. TraceIT hydrogel is intended to mark tissue for at least 3 months after injection E.
- Tissue MarkerK001807 · Advanced Uroscience, Inc. · May 3, 2001
- Coaptite Tissue Marker and Coaptite FN Tissue MarkerK012955 · Bioform, Inc. · Oct 22, 2001
- HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird…K253761 · Devicor Medical Products, Inc. · Jan 23, 2026
- MOLLI 2 SystemK253888 · Stryker Endoscopy · Dec 31, 2025
- SCOUT MD Surgical Guidance SystemK252892 · Merit Medical Systems, Inc. · Dec 19, 2025
- VizMark Preloaded Tissue Marker Device (VM-0001)K251989 · Breast-Med, Inc. · Dec 12, 2025
- MammoSTAR Biopsy Site IdentifierK251748 · Carbon Medical Technologies, Inc. · Jul 23, 2025
- UltraCor™ Twirl™ Breast Tissue MarkerK243642 · Bard Peripheral Vascular, Inc. · Mar 24, 2025
- SmartClip Secure Soft Tissue MarkerK233639 · Elucent Medical, Inc. · Dec 20, 2024
- Trilogy Tissue MarkerK240429 · Inrad, Inc. · Nov 7, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 5, 2012
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.4300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files